Genome-wide expression profiling of RNA interference of hepatitis B virus gene expression and replication

Cellular and Molecular Life Sciences

Volumn 61, Issue 16, 2004, Pages 2113-2124

  Li, Y ^a   Wasser, S ^b   Lim, S G ^b   Tan, T M C ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

cDNA microarray; Expression profiling; Hepatitis B; Short interfering RNA

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; SMALL INTERFERING RNA;

ARTICLE; CELL GROWTH; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE REPLICATION; GENOME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; NUCLEOTIDE SEQUENCE; REDUCTION; RNA INTERFERENCE; VIRION;

HEPATITIS B VIRUS; MAMMALIA;

EID: 4344603901     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4111-2     Document Type: Article

References (48)

1. Fire A., Xu S., Montgomery M., Kostas S., Driver S. and Mello C. C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811
2. Hamilton A. J. and Baulcombe D. C. (1999) A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286: 950-952
3. Zamore P. D., Tuschl T., Sharp P. A. and Bartel D. P. (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101: 25-33
4. Bernstein E., Caudy A. A., Hammond S. M. and Hannon G. J. (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366
5. Nykanen A., Haley B. and Zamore P. D. (2001) ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107: 309-321
6. Schwarz D. S., Hutvagner G., Haley B. and Zamore P. D. (2002) Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol. Cell. 10: 537-548
7. Hammond S. M., Bernstein E., Beach D. and Hannon G. J. (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404: 293-296
8. Hammond S. M., Boettcher S., Caudy A. A., Kobayashi R. and Hannon G. J. (2001) Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293: 1146-1150
9. Grishok A., Tabara H. and Mello C. C. (2000) Genetic requirements for inheritance of RNAi in C. elegans. Science 287: 2494-2497
10. Lee S. B. and Esteban M. (1994) The interferon-induced double-stranded RNA-activated protein kinase induces apotosis. Virology 199: 491-496
11. Kaufman R. J. (1999) Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor. Proc. Natl. Acad. Sci. USA 96: 11693-11695
12. Elbashir S. M., Harborth J., Lendeckel W., Yalcin A., Weber K. and Tuschl T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498
13. Stevenson M. (2003) Dissecting HIV-1 through RNA interference. Nat. Rev. Immunol. 3: 851-858
14. Saksela K. (2003) Human viruses under attack by small inhibitory RNA. Trends Microbiol. 11: 345-347
15. Haasnoot J. P. C., Cupac D. and Berkhout B. (2003) Inhibition of virus replication by RNA interference. J. Biomed. Sci. 10: 607-616
16. Robinson W. S. (1994) Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annu. Rev. Med. 45: 297-323
17. Beasley R., Hwang L., Lin C. and Chien C. (1981) Hepatocelluar carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2: 1129-1133
18. Xu R., Cai K., Zheng D., Ma H., Xu S. and Fan S. T. (2003) Molecular therapeutics of HBV. Curr. Gene Ther. 3: 341-355
19. Karayiannis P. (2003) Hepatitis B virus: old, new and future approaches to antiviral treatment. J. Antimicrob. Chemother. 51: 761-785
20. Hilleman M. R. (2003) Critical overview and outlook: pathogenesis, prevention and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 21: 4626-4649
21. Chen Y., Du D., Wu J., Chan C. P., Tan Y., Kung H. F. et al. (2003) Inhibition of hepatitis B virus replication by stably expressed shRNA. Biochem. Biophys. Res. Commun. 311: 398-404
22. Hamasaki K., Nakao K., Matsumoto K., Ichikawa T., Ishikawa H. and Eguchi K. (2003) Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett. 543: 51-54
23. Shlomai A. and Shaul Y. (2003) Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37: 764-770
24. McCaffery A., Nakai H., Pandey K., Huang Z., Salazar F., Xu H. et al. (2003) Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21: 639-644
25. Giladi H., Ketzinel-Gilad M., Rivkin L., Felig Y., Nussbaum O. and Galun E. (2003) Small interfering RNA inhibits hepatitis B virus replication in mice. Mol. Ther. 8: 769-776
26. Konishi M., Wu C. H. and Wu G. Y. (2003) Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology 38: 842-850
27. Ying C., De Clercq E. and Neyts J. (2003) Selective inhibition of hepatitis B virus replication by RNA interference. Biochem. Biophys. Res. Commun. 309: 482-484
28. Loeb K. R., Jerome K. R., Goddard J., Huang M., Cent A. and Corey L. (2000) High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 32: 626-629
29. Meyer T., Kneissel M., Mariani J. and Fournier B. (2000) In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism. Proc. Natl. Acad. Sci. USA 97: 9197-9202
30. Yguerabide J. and Yguerabide E. (1998a) Light scattering sub-microscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications: theory. Anal. Biochem. 262: 137-156
31. Yguerabide J. and Yguerabide E. (1998b) Light scattering sub-microscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications: experimental characterization. Anal. Biochem. 262: 157-176
32. Francois P., Bento M., Vaudaux P. and Schrenzel J. (2003) Comparison of fluorescence and resonance light scattering for highly sensitive microarray detection of bacterial pathogens. J. Microbiol. Methods 55: 755-762
33. Gollub J., Ball C. A., Binkley G., Demeter J., Finkelstein D. B., Hebert J. M. et al. (2003) The Stanford Microarray Database: data access and quality assessment tools. Nucleic Acids Res. 31: 94-96
34. Eisen M. B., Spellman P. T., Brown P. O. and Botstein D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95: 14863-14868
35. Harborth J., Elbashir S. M., Bechert K., Tuschl T. and Weber K. (2001) Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114: 4557-4565
36. Semizarov D., Frost L., Sarthy A., Kroeger P., Halbert D. N. and Fesik S. W. (2003) Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl. Acad. Sci. USA 100: 6347-6352
37. Chi J. T., Chang H. Y., Wang N. N., Chang D. S., Dunphy N. and Brown P. O. (2003) Genomewide view of gene silencing by small interfering RNAs. Proc. Natl. Acad. Sci. USA 100: 6343-6346
38. Otsuka M., Aizaki H., Kato N., Suzuki T., Miyamura T., Omata M. et al. (2003) Differential cellular gene expression induced by hepatitis B and C viruses. Biochem. Biophys. Res. Commun. 300: 443-447
39. Honda M., Kaneko S., Kawai H., Shirota Y. and Kobayashi K. (2001) Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology 120: 955-966
40. Sells M. A., Zelent A. Z., Shvartsman M. and Acs G. (1988) Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 62: 2836-2844
41. Norton P. A., Gong Q., Mehta A. S., Lu X. and Block T. M. (2003) Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells. J. Virol. 77: 5503-5506
42. Bridge A., Pebernard S., Ducraux A., Nicoulaz A. and Iggo R. (2003) Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34: 263-264
43. Tan T. M. C., Zhou L., Houssais S., Seet B. L., Jaenicke S., Peter F. et al. (2002) Intracellular inhibition of hepatitis B virus S gene expression by chimeric DNA-RNA phosphorothioate minimized ribozyme. Antisense Nucleic Acid Drug Dev. 12: 257-264
44. Klein C., Bock C. T., Wedemeyer H., Wustefeld T., Locarnini S., Dienes H. P. et al. (2003) Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 125: 9-18
45. Jackson A. L., Bartz S. R., Schelter J., Kobayashi S. V., Burchard J., Mao M. et al. (2003) Expression profiling reveals off-target regulation by RNAi. Nat. Biotechnol. 21: 635-637
46. Sledz C. A., Holko M., Veer M. J. de, Silverman R. H. and Williams B. R. (2003) Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5: 834-839
47. Persengiev S. P., Zhu X. and Green M. R.(2004) Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10: 12-18
48. Scacheri P. .C., Rozenblatt-Rosen O., Caplen N. J., Wolfsberg T. G., Umayam L., Lee J. C. et al. (2004) Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. USA 101: 1892-1897